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Background: The use of aspirin in the immediate postoperative period after coronary artery bypass grafting (CABG) has been shown to improve 
survival, graft patency and reduces ischemic events. Results of studies comparing the combination of clopidogrel and aspirin versus aspirin alone 
after CABG have been conflicting.
methods: A search strategy for MEDLINE and PubMed for all English and non-English articles including coronary bypass surgery and clopidogrel 
was created. Two reviewers independently performed the search and applied predetermined inclusion and exclusion criteria for randomized 
controlled trials (RCTs) comparing combination clopidogrel and aspirin therapy to aspirin alone after CABG. The primary outcome was graft patency 
and safety was measured using bleeding events. Outcomes were pooled using a fixed effects model and Mantel-Hansel odds ratios were used.
results: Four RCTs were included involving 761 patients (380 clopidogrel and aspirin, 381 aspirin alone) of whom 683 (89.8%) underwent follow-
up imaging of 2,252 bypass grafts to check for patency. Follow-up imaging took place at 50-365 days after surgery. Meta-analysis showed improved 
overall graft patency for patients receiving combined clopidogrel and aspirin versus aspirin alone (OR 1.58 [1.13,2.21]). Subgroup analysis by graft 
type showed a significant reduction in saphenous vein graft failure (OR 1.68 [1.16,2.43]) with clopidogrel use but not for internal mammary arteries 
or radial artery grafts. There was no difference detected in total bleeding events between the two groups (0.92 [0.44,1.92]).
conclusion: The addition of clopidogrel to aspirin in the immediate postoperative period after CABG is safe and improved overall graft patency 
driven mainly by a reduction in saphenous vein graft failure.
